Cannalogue hopes to conduct clinical trials on COVID-19 symptoms
Clinical research into cannabis and its many properties has led to some pretty amazing discoveries, but there is still plenty of work to do before we can fully understand all of the ways that it can help us. So far, we know that THC benefits are vast, as the cannabinoid can effectively treat many medical conditions such as PTSD, pain, and inflammation, but there is more to reveal, and we’ve barely scratched the surface with some cannabis components such as phytocannabinoids.
We have long known that cannabis can help with a variety of illnesses including those that are mental and physical, but very little research has been done to see if cannabis could work as a preventative measure against invaders like the new COVID-19. Though no one is claiming that cannabis could be a cure-all solution for the highly contagious disease, there is some logic behind this line of thinking.
In light of the latest risk to humanity, one Canadian cannabis company called Cannalogue has jumped the gun by applying for permission through Health Canada to conduct clinical trials, but the company says that for now, their research will focus on the therapeutic benefits that cannabis might offer for the wide range of uncomfortable COVID-19 symptoms.
It might sound like an unlikely scenario but using cannabis to treat a person with a virus isn’t exactly a new idea, and there is even some scientific evidence to back that up. We already know that endocannabinoid receptors can be found on immune cells that are spread throughout the human body. When you introduce THC or CBD to these receptors prior to an infection, the result is typically a reduced or slowed onset of symptoms that are not as severe.
Of course, this radical idea has yet to be proven, and it sets a high bar for anyone who decides to take on the challenge, which is likely why Cannalogue has decided to focus on treating the symptoms after a patient is infected, rather than before. There are also ethical considerations that must come into play when it comes to treating patients with severe ailments and no foreseeable cure or treatment.
Who is Cannalogue?
Cannalogue is a Canadian cannabis company that is hoping to embrace the anti-inflammatory and immunomodulatory benefits that cannabinoids in cannabis seem to possess. They are a huge advocate for the cannabis community, but they aren't exactly known for scientific research or clinical trials. Instead, their popularity stems from a robust online e-commerce platform that offers Canadians right across the country safe access to more weed strains than anywhere else in the world.
Could this clinical research lead to a cure?
The truth is that no one can predict what might come from this research into cannabinoids and phytocannabinoids, but what we hope to see is a workable and accessible treatment that is derived from a plant that not so long ago, was demonized. Now we see it praised as an essential service, and some of the world's biggest cannabis companies are pulling out all the stops to combat the COVID-19 pandemic.